Heart

All articles by Heart

ESPN’s Mike Greenberg shares AFib journey in J&J MedTech’s educational push
ESPN’s Mike Greenberg shares AFib journey in J&J MedTech’s educational push
Jack O'Brien
September 13, 2024
4:01 pm

Mike Greenberg is serving as the voice of J&J MedTech’s awareness campaign to underscore his AFib patient journey.

Alnylam’s Amvuttra slashes cardiovascular risk, faces investor skepticism
Alnylam’s Amvuttra slashes cardiovascular risk, faces investor skepticism
Lecia Bushak
August 30, 2024
12:54 pm

Despite reaching all of its primary endpoints, Amvuttra may still face competition from BridgeBio and Pfizer’s treatments.

Lilly’s weight-loss drug slashes heart failure risk by 38% in Phase 3 trial
Lilly’s weight-loss drug slashes heart failure risk by 38% in Phase 3 trial
Jack O'Brien
August 1, 2024
9:34 am

Lilly said tirzepatide led to a 38% reduction in the risk of heart failure outcomes compared to a placebo.

From Dr. Oz to heart valves: A tiny device charted a contentious path through the FDA
From Dr. Oz to heart valves: A tiny device charted a contentious path through the FDA
David Hilzenrath and Holly K. Hacker, KFF Health News
July 9, 2024
9:13 am

In 2013, the FDA approved an implantable device to treat leaky heart valves.

Patients facing death are opting for a lifesaving heart device — but at what risk?
Patients facing death are opting for a lifesaving heart device — but at what risk?
Daniel Chang and Holly K. Hacker, KFF Health News
December 19, 2023
2:05 pm

The HeartMate 3 is currently the only FDA-approved device of its kind in use.

Damar Hamlin, Abbott team on HeartMates, raise awareness about heart health
Damar Hamlin, Abbott team on HeartMates, raise awareness about heart health
Lecia Bushak
October 31, 2023
4:34 pm

Buffalo Bills safety Damar Hamlin is the new ambassador for Abbott’s HeartMates program, which connects cardiovascular patients and caregivers in a supportive community.

Roche pays Alnylam $310M upfront for heart drug
Roche pays Alnylam $310M upfront for heart drug
Lecia Bushak
July 24, 2023
2:51 pm

Alnylam and Roche will co-commercialize zilebesiran in the U.S. and split costs and profits equally.

Kareem Abdul-Jabbar laces up for BMS, Pfizer campaign targeting AFib
Kareem Abdul-Jabbar laces up for BMS, Pfizer campaign targeting AFib
Jack O'Brien
February 21, 2023
10:49 am

As part of the No Time to Wait effort, the NBA Hall of Famer reminds patients to be proactive with their health when dealing with AFib.

Zeno Group to roll out second phase of CDC Foundation’s Live to the Beat campaign
Zeno Group to roll out second phase of CDC Foundation’s Live to the Beat campaign
Lecia Bushak
February 16, 2023
9:30 am

The Live to the Beat campaign aims to encourage people in the Black community to improve their heart health.

Ahead of Super Bowl, Bayer launches Aspirin campaign linking sports fandom, heart health
Ahead of Super Bowl, Bayer launches Aspirin campaign linking sports fandom, heart health
Jack O'Brien
February 6, 2023
11:17 am

Bayer is also partnering with NBC Sports and Bally Sports to pursue multimedia content and regional media integrations featuring sports stars and TV icons.

  • From Our Partners